Publication | Closed Access

pH-Activatable cell penetrating peptide dimers for potent delivery of anticancer drug to triple-negative breast cancer

Cell-based Drug DeliveryNanomedicineEngineeringPolymer-drug ConjugateMedicineDrug DiscoveryPeptide TherapeuticTumor TargetingTriple-negative Breast CancerPeptide DimersPharmacologyRadiation OncologyAnticancer DrugBiomolecular Engineering